[Latest] Global Aesthetics Injectables Market Size/Share Worth USD 35,976.2 Million by 2033 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Se...
Anika Therapeutics Inc. (ANIK)
Last anika therapeutics inc. earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anikatherapeutics.com/investor-relations
Company Research
Source: Latest
Injectables Market size & share revenue was valued at approximately USD 14,125.1 Million in 2023 and is expected to reach USD 15,509.4 Million in 2024 and is expected to reach around USD 35,976.2 Million by 2033, at a CAGR of 9.8% between 2024 and 2033. The key market players listed in the report with their sales, revenues and strategies are Allergan plc (now part of AbbVie), Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sinclair Pharma plc, Suneva Medical Inc., Teoxane Laboratories, Anika Therapeutics Inc., Prollenium Medical Technologies Inc., Luminera Derm Ltd., Revance Therapeutics Inc., Ipsen Pharma, Laboratoires Vivacy SAS, SciVision Biotech Inc., Merz Aesthetics Inc., AQTIS Medical BV, and others. Austin, TX, USA, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “ Aesthetics Injectables Market Size, Trends and Insights By Product Type (Botulinum Toxin, Dermal Fillers, Collagen Stimulators, Others), By Application (Facial Line C
Show less
Read more
Impact Snapshot
Event Time:
ANIK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIK alerts
High impacting Anika Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
ANIK
News
- Anika Therapeutics, Inc. (NASDAQ: ANIK) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $37.00 to $25.00. They now have an "outperform" rating on the stock.MarketBeat
- Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Arthrosurface Returns to it Roots Following Divestiture from Anika TherapeuticsPR Newswire
- Anika Reports Third Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
ANIK
Earnings
- 10/31/24 - Miss
ANIK
Sec Filings
- 11/4/24 - Form 10-Q
- 10/31/24 - Form 8-K
- 10/31/24 - Form 8-K
- ANIK's page on the SEC website